Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. (Q53081345)

11 May 2018

title

Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. (English)

1 reference

11 May 2018

author name string

Ziqiang Li

1

1 reference

11 May 2018

Mei Tang

2

1 reference

11 May 2018

Bo Ling

3

1 reference

11 May 2018

Shiying Liu

4

1 reference

11 May 2018

Yu Zheng

5

1 reference

11 May 2018

Chunlai Nie

6

1 reference

11 May 2018

Zhu Yuan

7

1 reference

11 May 2018

Liangxue Zhou

8

1 reference

11 May 2018

Gang Guo

9

1 reference

11 May 2018

Aiping Tong

10

1 reference

11 May 2018

Yuquan Wei

11

1 reference

11 May 2018

publication date

27 November 2013

1 reference

11 May 2018

Journal of Molecular Medicine

published in

1 reference

11 May 2018

volume

92

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

291-303

1 reference

11 May 2018

Crystal structures of S100A6 in the Ca(2 )-free and Ca(2 )-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution

cites work

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

The S100 family of EF-hand calcium-binding proteins: functions and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Calcyclin as a marker of human epithelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100P promotes pancreatic cancer growth, survival, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2 )-binding proteins S100A6 and S100A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Specific expression of osteopontin and S100A6 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Involvement of S100A14 Protein in Cell Invasion by Affecting Expression and Function of Matrix Metalloproteinase (MMP)-2 via p53-dependent Transcriptional Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Structure of the S100A6 Complex with a Fragment from the C-Terminal Domain of Siah-1 Interacting Protein: A Novel Mode for S100 Protein Target Recognition † ‡

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Oncogenic beta-catenin signaling networks in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00109-013-1104-3

Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas

21 January 2018

1 reference

12 December 2020

Structural and functional analysis of a growth-regulated gene, the human calcyclin

1 reference

12 December 2020

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

1 reference

12 December 2020

Expression of S100A2 and S100A6 in thyroid carcinomas

1 reference

12 December 2020

10.1007/S00109-013-1104-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018